KeyCorp Cuts HealthEquity (NASDAQ:HQY) Price Target to $110.00

HealthEquity (NASDAQ:HQY) had its price objective reduced by KeyCorp from $120.00 to $110.00 in a report issued on Monday,Benzinga reports. The firm currently has an “overweight” rating on the stock. KeyCorp’s price target suggests a potential upside of 29.59% from the company’s current price.

Other equities analysts also recently issued research reports about the stock. Royal Bank of Canada increased their price target on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Tuesday, December 10th. Wells Fargo & Company increased their target price on shares of HealthEquity from $110.00 to $125.00 and gave the company an “overweight” rating in a report on Wednesday, February 26th. Raymond James boosted their price target on HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 25th. Mizuho began coverage on HealthEquity in a report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price target on the stock. Finally, JMP Securities lifted their price objective on HealthEquity from $105.00 to $107.00 and gave the stock a “market outperform” rating in a report on Tuesday, December 10th. One equities research analyst has rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $113.69.

HealthEquity Trading Up 0.3 %

Shares of HQY stock opened at $84.88 on Monday. The business’s fifty day moving average price is $104.90 and its 200 day moving average price is $95.76. The firm has a market capitalization of $7.36 billion, a PE ratio of 77.87, a P/E/G ratio of 1.60 and a beta of 0.62. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20. HealthEquity has a 1-year low of $65.01 and a 1-year high of $115.59.

Insider Buying and Selling

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the firm’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the sale, the director now directly owns 78,219 shares of the company’s stock, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 2.20% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On HealthEquity

Institutional investors have recently modified their holdings of the company. Arcadia Investment Management Corp MI purchased a new stake in HealthEquity in the 4th quarter worth approximately $26,000. Transce3nd LLC acquired a new stake in shares of HealthEquity during the fourth quarter worth $29,000. Smartleaf Asset Management LLC boosted its holdings in shares of HealthEquity by 34.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company’s stock worth $37,000 after purchasing an additional 98 shares during the last quarter. Proficio Capital Partners LLC purchased a new stake in shares of HealthEquity in the fourth quarter valued at $39,000. Finally, UMB Bank n.a. increased its stake in HealthEquity by 65.6% in the fourth quarter. UMB Bank n.a. now owns 414 shares of the company’s stock valued at $40,000 after purchasing an additional 164 shares during the last quarter. Institutional investors and hedge funds own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.